Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.
Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results